Found: 5
Select item for more details and to access through your institution.
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 430, doi. 10.3390/cancers14020430
- By:
- Publication type:
- Article
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 744, doi. 10.3390/cancers13040744
- By:
- Publication type:
- Article
Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1053, doi. 10.1002/ijc.33898
- By:
- Publication type:
- Article
Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma.
- Published in:
- Biomedicines, 2023, v. 11, n. 9, p. 2471, doi. 10.3390/biomedicines11092471
- By:
- Publication type:
- Article
Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 16, p. 2507, doi. 10.3390/cells11162507
- By:
- Publication type:
- Article